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Summary
 Background Apocrine adenocarcinoma of the skin is a rare entity. It is characterized by slow-
ly enlarging, painless, indurate nodules or plaques and often misdiagnosed as 
benign skin tumours. Although these tumours show characteristic tubular struc-
tures mixed with cellular cords and have some pattern of cytokeratins, primary 
apocrine carcinoma is indistinguishable from metastatic mammary ductal carci-
nomas. Like other apocrine carcinomas it is radioresistant and therefore surgi-
cal resection is the method of choice in treatment of patients. Distant metastas-
es have been reported in a limited number of published cases.
 Aim We present the case of a 66-year-old woman with apocrine adenocarcinoma of 
the left axillary area with local lymph node and distant metastases.
 Case Report A 66-year-old woman was admitted to hospital because of a tumour located in the 
skin of the axillary area. After incision biopsy lobular breast carcinoma was ini-
tially suspected. Correlation of clinical, histological and immunohistochemical 
data allowed the rare apocrine adenocarcinoma to be diagnosed. The tumour 
was excised with axillary lymph nodes. Next chemotherapy was applied as palli-
ative treatment.
 Conclusions Our observations lead us to following conclusions: (I) apocrine adenocarcino-
ma is a rare and difﬁ cult to diagnose tumour requiring special examination; (II) 
metastases to lung, liver and bones cause worse prognoses; (III) a wide surgical 
excision is the treatment of choice.
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BACKGROUND
Apocrine adenocarcinoma is a rare entity and 
most documented cases have been located in the 
axilla area [1,2]. Clinically, apocrine adenocar-
cinoma is recognized by the presence of slowly 
enlarging, painless, indurate nodules or plaques. 
Therefore it is frequently confused with benign 
skin tumours [1,2]. The scalp, eyelid (Moll’s gland 
carcinoma), ear, anogenital region, chest, lip 
and nipple areas are occasionally affected [1–4]. 
Confusion with benign tumours and less aggres-
sive malignancies, such as dermatoﬁ broma, can 
lead to inadequate initial treatment and exten-
sive recurrences [1–4]. Histologically, these tu-
mours are characterized by the presence of tu-
bular structures mixed with variable amounts of 
cellular cords. The dermis is inﬁ ltrated and the 
subcutaneous fat and the perineural spaces are 
in most cases involved. The stroma is nearly al-
ways desmoplastic and hyalinized. Epidermal 
contraction and ulceration sometimes occur. 
Expression of cytokeratins reveals the following 
pattern: AE1/AE3, CAM 5.2, EMA, CEA, CK15 
and GCDFP-15. Lysozyme, a´1-antichymotrypsin 
and S-100 protein are also present in some tu-
mours. Primary cutaneous apocrine adenocarci-
noma is indistinguishable in terms of histology 
from metastatic mammary ductal carcinoma, es-
pecially with apocrine differentiation. Since most 
apocrine carcinomas are radioresistant, local wide 
surgical excision is recommended. Chemotherapy 
and radiotherapy have a limited role in advanced 
cancers. Lymph node metastases have been doc-
umented in some cases. According to the litera-
ture, distant metastases are encountered in the 
minority of published cases [1,2].
AIM
In the following report we present the case of a 
66-year-old woman with apocrine adenocarcino-
ma of the left axillary area with local lymph and 
distant metastases.
CASE DESCRIPTION
In December 2004, a 66-year-old Polish wom-
an was examined in an ambulatory of Great 
Poland Cancer Centre by a surgeon because of 
a slow-growing skin tumour. Physical examina-
tion showed that the tumour was located in the 
skin of the axillary area. The tumour appeared 
as a painless, indurate, irregular nodule measur-
ing 6×8cm. The tumour seemed to have invad-
ed the surrounding subcutaneous tissue and un-
derlying axillary lymph nodes. The overlying skin 
was smooth like the skin of a scar.
Material obtained in ﬁ ne needle aspiration bi-
opsy of the mass was insufﬁ cient for diagno-
sis. Therefore, the patient had an incision bi-
opsy in the surgical ambulatory. Histological 
study found proliferated ducts inﬁ ltrating the 
dermis and subcutaneous fat tissue, which sug-
gested a lobular breast carcinoma or sclerosing 
sweat duct carcinoma. Immunohistochemical 
study performed on parafﬁ n-embedded tissue 
sections showed positive staining for cytokerat-
ins AE1/AE3, CAM5.2, GCDFP-15 (gross cystic 
disease ﬂ uid protein-15) and negative reactivi-
ty with antibodies against S-100 protein, oestro-
gen receptor (ER) and progesterone receptor 
(PgR). Clinical data (axillary area involvement, 
no breast tumours, slow growing) correlated with 
histological and immunohistochemical ﬁ ndings 
suggested a rare malignant skin tumour arising 
from the apocrine glands.
In February 2005 the patient was admitted to the 
2nd Department of Oncological Surgery of Great 
Poland Cancer Centre, Poznań. Presurgical ex-
aminations were ordered. Abdominal ultrasound 
showed a tumour in the 4th segment of the liver 
measuring 11mm, which was suspected of metas-
tasis. Haematological and biochemical tests and 
x-ray chest examination were normal. We rec-
ommended wide tumour excision with axillary 
lymph node dissection. Consequently, after she 
had agreed, she underwent the operation. The 
postoperative course was uneventful and the pa-
tient was discharged on the 5th day after the op-
eration. Histological examination of the excised 
tumour revealed proliferating ducts situated by 
two layers of epithelium inﬁ ltrating the dermis 
and subcutaneous tissue. There was a diffuse 
growth pattern in the deeper parts of dermis and 
involvement of subcutaneous fat. The stroma was 
desmoplastic and hyalinized inﬁ ltrated by pleo-
morphic cells similar to those observed in breast 
lobular carcinoma. Hyperplastic apocrine glands 
were found in close proximity to the tumour. 
Cancer cells contained abundant eosinophilic 
cytoplasm. Nuclei were large and vesicular with 
conspicuous nucleoli. The carcinoma cells were 
characterized by a tubular growth pattern and 
formed solid foci. Lipid tissue was inﬁ ltrating. 
All examined lymph nodes were metastatic with 
inﬁ ltration of perinodal fat tissue. Histological 
examination correlated with clinical and immu-
nohistochemical data established the diagnosis 
of apocrine adenocarcinoma.
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The patient was further observed as an ambulato-
ry treated outpatient. She underwent a metastatic 
work-up. CT imaging showed a hypodensic meta-
static lesion measuring 11mm in diameter in the 
right lobe of the liver. There were bone metastases 
in the lumbar and thoracic part of the spine and 
osteolytic multifocal metastasis in the hip bone.
We recommended chemotherapy and palliative 
treatment. The patient underwent an AC chem-
otherapy course with Adriablastin and Endoxan 
in standard doses (Endoxan 905mg, Adriablastin 
90mg in 3-week cycle). The patient was under 
symptomatic and palliative treatment and is still 
being treated at the Great Poland Cancer Centre 
as an outpatient.
DISCUSSION
Apocrine adenocarcinoma of the skin is a rare 
and usually misdiagnosed malignant entity. The 
lesion was suspected to be a benign skin tumour 
at ﬁ rst clinical examination. It is recognized by 
the presence of slowly enlarging, painless, in-
durate nodule. Confusion with benign tumours 
led to inadequate initial treatment and extensive 
recurrences [1–3]. In the presented case there 
was no CT imaging in presurgical examinations. 
Clinical experience suggested a favourable prog-
nosis with no distant metastases; hence local wide 
excision was proposed. After incision biopsy lob-
ular breast carcinoma was initially suspected. 
Apocrinal tumours and ductal breast carcinoma 
form ductal structures, although similar cellular 
atypia, sclerotic stroma, subcutaneous and mu-
sucular invasion are observed in both types of 
neoplasm [5–9]. Differentiation between benign 
and other malignant variants of apocrine lesions 
is difﬁ cult [7,10,11]. Our experience allowed us 
to conclude that only wide excision biopsy and 
subsequent careful microscopic examination lead 
to appropriate diagnosis of an apocrine adeno-
carcinoma. Cytoplasm labelling for cytokeratin 
7 (CK7) and EMA, known as distal tubule mark-
er, and cytokeratins AE1/AE2 and CAM 5.2 sup-
ports an eccrine origin [12]. The presence of 
S-100 and CEA immunoreactivity also suggests 
eccrine differentiation [2] (S-100 protein in our 
cases was negative, CEA not used). The eccrine 
ductal structures additionally expressed gross cyst-
ic disease ﬂ uid protein – 15 (GCDFP-15) [13]. 
Clinical data, microscopic examination, immuno-
histochemical studies (positive staining for cytok-
eratin AE1/AE3, CK7, CAM5.2, GCDFP-15 and 
negative reactivity with antibodies against S-100 
protein, oestrogen and progesterone receptor) 
allowed apocrine adenocarcinoma to be ﬁ nally 
distinguished from ductal breast carcinoma or 
benign syringoma in the presented case.
Normal apocrine glands are often found in close 
proximity to the tumour and occasionally long-
standing pre-existent benign apocrinal lesions 
may be evident, raising the possibility of malig-
nant transformation [1,2]. The problem for im-
munohistochemical investigations is whether 
apocrine hyperplasia is a precursor of cancer or 
whether apocrine hyperplasia and adenoma may 
be successive steps in the linear progression to 
apocrine adenocarcinoma [2]. Apocrine adeno-
carcinomas have to be distinguished from metas-
tases, especially from breast cancer. Apocrine cells 
may be present in up to 50% of cases of DCIS, al-
though Eusebi et al. [6,14] consider it as an in-
frequently recognized phenomenon. The most 
useful discrimination for making such a distinc-
tion is a detailed clinical history and careful ex-
amination of the patient. Immunohistochemistry 
is not very useful in making the differential diag-
nosis because the immunophenotype of apocrine 
adenocarcinoma (positive staining for cytokerat-
ins AE1/AE3, CAM 5.2, GCDFP 15 and negativ-
ity for ER and PR) is not speciﬁ c and all of the 
studied antigens can be observed, to varying ex-
tent, in metastases of visceral tumours.
The histological analysis suggested that the wide 
spectrum of morphologic appearances may be 
due to the variable grade of differentiation of tu-
mours. Apocrine adenocarcimoma appears as a 
tumour that frequently recurs and is capable of 
metastasizing [1,2]. Lymph node involvement has 
been documented in some cases of this tumour. 
Our case showed regional lymph node invasion. 
Presurgical exams showed no symptoms of distant 
metastases. The patient underwent wide excision 
with axillary lymphadenectomy. The histological 
ﬁ ndings revealed massive lymph node metastases 
with inﬁ ltration of perinodal fat tissue.
The patient was further observed as an ambulato-
ry treated outpatient. When seen 2 months after 
the operation she suffered from spine, hip and 
thoracic pain. Metastatic work-up showed a hy-
podensic, metastatic lesion 11mm in diameter in 
the right lobe of the liver; there were bone me-
tastases in the lumbar and thoracic part of the 
spine and hip bone osteolytic multifocal metas-
tasis in CT imaging. According to the literature 
data sites of apocrine adenocarcinoma metastases 
include nodes, lungs, liver and bone [15,16]. In 
the majority of cases deposits from undiagnosed 
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visceral and breast adenocarcinomas are virtually 
indistinguishable microscopically from apocrine 
tumours and must be ruled out before a diagno-
sis of apocrine cancer is made [7].
The recommended treatment of apocrine aden-
ocarcinoma is wide surgical excision along with 
regional lymph node dissection in the presence 
of clinically positive nodes. This kind of tumour 
is rather chemoresistant and chemotherapy has 
been infrequently employed [17]. In this case, 
palliative chemotherapy was applied but there was 
no evidence of beneﬁ ts of this treatment.
CONCLUSIONS
I.  Apocrine adenocarcinoma is a rare malignan-
cy with high metastatic and recurrence poten-
tial. The region of the axilla is the most com-
mon site of occurrence and it usually spreads 
to lymph nodes. It is recognized by the pres-
ence of slowly enlarging, painless, indurated 
nodule. Confusion with benign tumours led 
to inadequate initial treatment and extensive 
recurrences.
Differentiation diagnosis is often difﬁ cult. The 
most useful discrimination for making such a dis-
tinction is a detailed clinical history and careful 
examination of the patient. Findings that distin-
guish apocrine adenocarcinoma from breast car-
cinomas or other tumours are: clinical data and 
microscopic examination. Immunohistochemical 
studies are, in this case, of lesser value.
II.  Lungs, liver and bones are the distant sites 
of metastases that result in fatal course of 
the disease.
III.  A wide surgical excision is the treatment of 
choice with clearance of draining lymph 
nodes. The role of adjuvant chemo- and ra-
diotherapy is not established.
IV.  The reported case demonstrates the difﬁ cul-
ties in diagnosing apocrine adenocarcinomas 
and indicates that this entity should be con-
sidered in the differential diagnosis of slow-
ly growing skin tumours with clinically be-
nign features in the region of the axilla.
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